<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><front><journal-meta><journal-id journal-id-type="nlm-ta">Diabetes Care</journal-id><journal-id journal-id-type="publisher-id">diacare</journal-id><journal-title>Diabetes Care</journal-title><issn pub-type="ppub">0149-5992</issn><issn pub-type="epub">1935-5548</issn><publisher><publisher-name>American Diabetes Association</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">31102056</article-id><article-id pub-id-type="doi">10.2337/dc08-0368</article-id><article-id pub-id-type="pmid">18689695</article-id><article-categories><subj-group subj-group-type="heading"><subject>Cardiovascular and Metabolic Risk</subject></subj-group></article-categories><title-group><article-title>Predicting Diabetes: Clinical, Biological, and Genetic Approaches</article-title><subtitle>Data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR) </subtitle></title-group><contrib-group><contrib contrib-type="author"><name><surname>Balkau</surname><given-names>Beverley</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Lange</surname><given-names>C&#x000e9;line</given-names></name><degrees>BSC</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Fezeu</surname><given-names>Leopold</given-names></name><degrees>MD, MSC</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Tichet</surname><given-names>Jean</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>de Lauzon-Guillain</surname><given-names>Blandine</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Czernichow</surname><given-names>Sebastien</given-names></name><degrees>MD, PHD</degrees><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="aff" rid="aff5">5</xref></contrib><contrib contrib-type="author"><name><surname>Fumeron</surname><given-names>Frederic</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="aff6">6</xref><xref ref-type="aff" rid="aff7">7</xref></contrib><contrib contrib-type="author"><name><surname>Froguel</surname><given-names>Philippe</given-names></name><degrees>MD, PHD</degrees><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Vaxillaire</surname><given-names>Martine</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Cauchi</surname><given-names>Stephane</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="aff8">8</xref><xref ref-type="aff" rid="aff9">9</xref><xref ref-type="aff" rid="aff10">10</xref></contrib><contrib contrib-type="author"><name><surname>Ducimeti&#x000e8;re</surname><given-names>Pierre</given-names></name><degrees>PHD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib><contrib contrib-type="author"><name><surname>Eschw&#x000e8;ge</surname><given-names>Eveline</given-names></name><degrees>MD</degrees><xref ref-type="aff" rid="aff1">1</xref></contrib></contrib-group><aff id="aff1"><label>1</label>INSERM U780-IFR69, Villejuif, France/University Paris-Sud, Orsay, France</aff><aff id="aff2"><label>2</label>Institut inter R&#x000e9;gional pour la Sant&#x000e9;, La Riche, France</aff><aff id="aff3"><label>3</label>INSERM, Regional INSERM Research Group 20, New INSERM Research Group 4045, Institut Gustave-Roussy, Villejuif, France</aff><aff id="aff4"><label>4</label>Nutritional Epidemiology Research Unit, UMR U557 INSERM, U1125 French National Institute for Agricultural Research, National School of Arts and Trades, University Paris 13, Center for Research on Human Nutrition&#x02013;Ile de France, Bobigny, France</aff><aff id="aff5"><label>5</label>Public Health Department, Avicenne Hospital, Bobigny, France</aff><aff id="aff6"><label>6</label>INSERM U695, Paris, France</aff><aff id="aff7"><label>7</label>Ren&#x000e9; Diderot-Paris University, Paris, France</aff><aff id="aff8"><label>8</label>UMR 8090 and Institute of Biology, Lille, France</aff><aff id="aff9"><label>9</label>Pasteur Institute, Lille, France</aff><aff id="aff10"><label>10</label>Lille 2 University, Lille, France</aff><author-notes><fn><p>Corresponding author: Beverley Balkau, <email>beverley.balkau&#x00040;inserm.fr</email></p></fn></author-notes><pub-date pub-type="ppub"><month>10</month><year>2008</year></pub-date><volume>31</volume><issue>10</issue><fpage>2056</fpage><lpage>2061</lpage><history><date date-type="received"><day>20</day><month>2</month><year>2008</year></date><date date-type="accepted"><day>16</day><month>7</month><year>2008</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2008, American Diabetes Association</copyright-statement><license license-type="open-access"><p>Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc-nd/3.0/">http://creativecommons.org/licenses/by-nc-nd/3.0/</ext-link> for details.</p></license></permissions><self-uri xlink:title="pdf" xlink:href="zdc01008002056.pdf"/><abstract><p><bold>OBJECTIVE</bold>&#x02014;To provide a simple clinical diabetes risk score and to identify characteristics that predict later diabetes using variables available in the clinic setting as well as biological variables and polymorphisms.</p><p><bold>RESEARCH DESIGN AND METHODS</bold>&#x02014;Incident diabetes was studied in 1,863 men and 1,954 women, 30&#x02013;65 years of age at baseline, with diabetes defined by treatment or by fasting plasma glucose &#x02265;7.0 mmol/l at 3-yearly examinations over 9 years. Sex-specific logistic regression equations were used to select variables for prediction.</p><p><bold>RESULTS</bold>&#x02014;A total of 140 men and 63 women developed diabetes. The predictive clinical variables were waist circumference and hypertension in both sexes, smoking in men, and diabetes in the family in women. Discrimination, as measured by the area under the receiver operating curves (AROCs), were 0.713 for men and 0.827 for women, a little higher than for the Finish Diabetes Risk (FINDRISC) score, with fewer variables in the score. Combining clinical and biological variables, the predictive equation included fasting glucose, waist circumference, smoking, and &#x003b3;-glutamyltransferase for men and fasting glucose, BMI, triglycerides, and diabetes in family for women. The number of <italic>TCF7L2</italic> and <italic>IL6</italic> deleterious alleles was predictive in both sexes, but after including the above clinical and biological variables, this variable was only predictive in women (<italic>P</italic> &#x0003c; 0.03) and the AROC statistics increased only marginally.</p><p><bold>CONCLUSIONS</bold>&#x02014;The best clinical predictor of diabetes is adiposity, and baseline glucose is the best biological predictor. Clinical and biological predictors differed marginally between men and women. The genetic polymorphisms added little to the prediction of diabetes.</p></abstract></article-meta><notes><fn-group><fn><p>Published ahead of print at <ext-link ext-link-type="uri" xlink:href="http://care.diabetesjournals.org">http://care.diabetesjournals.org</ext-link> on 8 August 2008.</p><p>The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked &#x0201c;advertisement&#x0201d; in accordance with 18 U.S.C Section 1734 solely to indicate this fact.</p></fn></fn-group></notes></front><body><p>A number of diabetes risk scores have been developed to detect those who should be screened for diabetes (<xref ref-type="bibr" rid="r1">1</xref>). In the Data from an Epidemiological Study on the Insulin Resistance Syndrome (DESIR) cohort, we have previously studied the anthropometric variables associated with diabetic levels of fasting glucose and found that BMI, waist circumference, and waist-to-hip ratio were equally useful in the identification of individuals with undiagnosed diabetes (<xref ref-type="bibr" rid="r2">2</xref>).</p><p>The first score to identify lifestyle and clinical parameters predictive of later diabetes was developed by Lindstr&#x000f6;m and Tuomilehto (<xref ref-type="bibr" rid="r3">3</xref>), from a population-based sample of people who responded to questionnaires in 1987; 10-year incident diabetes was identified from a registry of diabetes treatment. A similar Finnish Diabetes Risk Score (FINDRISC) was used in a cross-sectional study (<xref ref-type="bibr" rid="r4">4</xref>). In the American Atherosclerosis Risk in Communities (ARIC) study and in a Thai population, predictive risk factors were also identified, wherein diabetes was defined by treatment or diabetic levels of fasting and 2-h glucose from an oral glucose tolerance test (<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r6">6</xref>). More recently, Simmons et al. (<xref ref-type="bibr" rid="r7">7</xref>) published a score from the European Prospective Investigation into Cancer Study (EPIC)-Norfolk study, wherein incident diabetes was defined by clinical identification of diabetes or A1C &#x0003e;7&#x00025; and dietary factors and physical activity were included. Finally, dietary and other noninvasive factors associated with 5-year incident, self-reported cases of diabetes were identified in the large EPIC-Potsdam study (<xref ref-type="bibr" rid="r8">8</xref>).</p><p>In the San Antonio Study, Stern et al. (<xref ref-type="bibr" rid="r9">9</xref>) published a score based on prospective clinical and biological data. In the Framingham cohort, four scores were proposed: a clinical score and three scores with both clinical and biological factors with incident diabetes identified at follow-up by diabetic treatment and/or fasting glucose levels (<xref ref-type="bibr" rid="r10">10</xref>). Other studies on diabetes risk factors include one in French men with impaired fasting glucose (6.1&#x02013;6.9 mmol/l), which identified lifestyle and clinical and biological factors predictive of diabetes (<xref ref-type="bibr" rid="r11">11</xref>).</p><p>As risk scores cannot always be generalized from one country to another (<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r13">13</xref>), the aim of this study was to describe sex-specific lifestyle and clinical diabetes risk factors in a French population followed over 9 years in order to aid in identifying those at risk for incident diabetes. Additional aims were to study the impact of biological factors and genetic polymorphisms in predicting diabetes.</p><sec><title>RESEARCH DESIGN AND METHODS</title><p>The study population consisted of men and women aged 30&#x02013;64 years who participated in the 9-year follow-up study, DESIR. Participants were recruited from volunteers who were offered periodic health examinations free of charge by the French Social Security at 10 health examination centers in western France. All subjects provided informed written consent, and the protocol was approved by an ethics committee.</p><p>Incident cases of diabetes were identified by treatment for diabetes or a fasting plasma glucose &#x02265;7.0 mmol/l at one of the 3-yearly examinations; after exclusion of individuals with diabetes at baseline and those with unknown diabetes status at the 9-year examination, 1,863 men and 1,954 women with glucose, BMI, and waist circumference measures available at baseline were included in the study.</p><p>Two measures of blood pressure, using a mercury sphygmomanometer, and heart rate were taken in a supine position after 5 min of rest, and mean values were used for analyses. Weight and height were measured in lightly clad participants, and BMI was calculated. Waist circumference, the smallest circumference between the lower ribs and the iliac crest, was also measured.</p><p>The examining physician noted the family history of diabetes and menopausal status in a clinical questionnaire; treatment for diabetes and hypertension and lipids were recorded. Hypertension was defined by systolic/diastolic blood pressure of at least 140/90 mmHg or being on antihypertensive medication. Smoking habits, alcohol consumption (glasses of wine, beer, cider, and spirits per day), and degree of physical activity (at home, at work, and sport) were assessed using a self-administered questionnaire.</p><p>All biochemical measurements were from one of four health center laboratories located in France at Blois, Chartres, LA Riche, or Orl&#x000e9;ans. Fasting plasma glucose, measured by the glucose oxidase method, was applied to fluoro-oxalated plasma using a Technicon RA100 (Bayer Diagnostics, Puteaux, France) or a Specific or a Delta device (Konelab, Evry, France). Total cholesterol, HDL cholesterol, triglycerides, alanine aminotransferase (ALT), &#x003b3;-glutamyltransferase (GGT), and creatinine were assayed by DAX 24 (Bayer Diagnostics) or KONE (Konelab). Insulin was quantified by microparticle enzyme immunoassay with an automated analyzer (IMX; Abbott, Rungis, France). White cell counts were determined by a Technicon H&#x0002a; or Technicon H3RTX (Bayer Diagnostics), a JT2 (Beckman/Coulter, Roissy, France), or an Argos (ABX, Montpellier, France). Interlaboratory variability was assessed monthly on normal and pathological values for each biologic variable.</p><p>Single nucleotide polymorphism (SNP) genotyping was performed with SNPlex Technology (Applied Biosystems, Foster City, CA) based on oligonucleotide ligation assay combined with multiplex PCR target amplification (<ext-link ext-link-type="uri" xlink:href="http://www.appliedbiosystems.com">http://www.appliedbiosystems.com</ext-link>) (<xref ref-type="bibr" rid="r14">14</xref>).</p><sec><title>Statistical methods</title><p>Statistical analysis was performed using SAS version 9.1 (SAS Institute, Cary, NC). Alcohol intake, BMI, fasting glucose, insulin, ALT, GGT, triglycerides, and white blood cell count were log-transformed because of their skewed distributions.</p><p>Characteristics of men and women with and without incident diabetes are shown as means &#x000b1; SD or <italic>n</italic> (&#x00025;) and compared by <italic>t</italic> or &#x003c7;<sup>2</sup> tests or by linear regression for the polymorphisms with additive models. The logistic model was used to test for interactions with sex, and <italic>P</italic> are reported; significant interactions (<italic>P</italic> &#x0003c; 0.01) provided the rational for sex-specific models.</p><p>The linearity of continuous parameters in logistic analyses was studied by adding a squared term and comparing nested models by likelihood ratio tests; all variables were linearly related with the logit of diabetes incidence except for fasting glucose (log transformed); in the models, glucose(log) was centered by subtracting its mean, and its square was systematically included.</p><p>Parsimonious logistic regression models were selected using forwards and backwards as well best model selection criteria using all parameters; the Hosmer-Lemeshow goodness-of-fit test was the principal criteria for selection of a model. Interactions with sex were tested. The area under the receiver operating characteristic curve (AROC) for sensitivity-specificity quantified the discrimination between diabetic and nondiabetic participants. Bootstrap sampling was used to validate the choice of variables in the models, with 1,000 samples of the same sizes as the study populations. The choice of variables was also validated in the Cox model.</p><p>To derive a simple clinical score from the clinical equations, we used the &#x003b2;-coefficients from the logistic regression analysis; for waist circumference, four groups were defined, linearly, from the approximate sex-specific quartiles. The score was validated in two French cohorts: E3N and SU.VI.MAX (<xref ref-type="bibr" rid="r15">15</xref>,<xref ref-type="bibr" rid="r16">16</xref>) (online appendix Fig. 1 &#x0005b;available at <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.2337/dc08-0368">http://dx.doi.org/10.2337/dc08-0368</ext-link>&#x0005d;). The first study identified incident diabetes by self-questionnaire or treatment reimbursement, the second by fasting glucose or treatment.</p><p>Four polymorphisms were chosen for study (glucokinase: <italic>GCK-30</italic> G/A rs1799884, interleukine 6: <italic>IL6-174</italic> G/C rs1800795, and Kir6.2: <italic>KCNJ11</italic> E23K rs5219 and <italic>TCF7L2</italic> rs7903146) following previous analyses in this population (<xref ref-type="bibr" rid="r14">14</xref>). Additive models discriminated best between diabetic and nondiabetic people. For the two polymorphisms found to be the most related with incident diabetes (IL6 and TCF7L2), the number of deleterious alleles (as a continuous variable) was calculated and added as a variable to the (clinical &#x0002b; biological) equations chosen above. As this analysis aimed to determine those who should be screened for diabetes, we have analyzed all individuals and have not excluded those born outside of mainland France. This analysis was on a smaller population (1,655 men and 1,740 women), where these two polymorphisms were available.</p><p>We compared our clinical risk score with the FINDRISC score (<xref ref-type="bibr" rid="r3">3</xref>) using the AROC statistic; FINDRISC includes age, BMI, waist circumference, antihypertensive medication, physical activity, previously known high glucose, and daily consumption of vegetables, and fruits or berries; we were not able to include the latter two items. Our (clinical &#x0002b; biological) equation was compared with the Stern equation, including age, sex, fasting glucose, systolic blood pressure, HDL cholesterol, BMI, and diabetes in the family; we did not include the factor for coding Mexican Americans (<xref ref-type="bibr" rid="r9">9</xref>).</p></sec></sec><sec><title>RESULTS</title><p>In the DESIR population, 140 men and 63 women had incident diabetes.</p><sec><title>Clinical predictors of incident diabetes</title><p>All of the clinical variables showed similar relations with incident diabetes in both men and women with the exception of diabetes in the family: noted for 43&#x00025; of women with incident diabetes and 19&#x00025; without diabetes and for 20 and 18&#x00025; of men, respectively (<italic>P</italic> for sex interaction &#x0003d; 0.003) (<xref ref-type="table" rid="t1">Table 1</xref>).</p><p>The first most predictive variable was waist circumference, closely followed by BMI, in both sexes. The selected model in men included waist circumference, smoking, and hypertension and in women included waist circumference, diabetes in the family, and hypertension (<xref ref-type="table" rid="t2">Table 2</xref>). These models showed a good fit (Hosmer-Lemeshow <italic>P</italic> &#x0003d; 0.7 and 0.6 in men and women, respectively) and well discriminated the diabetic and nondiabetic populations (AROC 0.733 and 0.839, respectively). In the bootstrap samples, these were the most frequently chosen models. These variables were also chosen by the Cox modeling.</p></sec><sec><title>Clinical risk score</title><p>Clinical risk scores were derived (<xref ref-type="table" rid="t3">Table 3</xref>) from the above equations. These scores showed a good fit (Hosmer-Lemeshow <italic>P</italic> &#x0003d; 0.8 and 0.9 in men and women, respectively), and the discrimination was similar to the more exact equation with continuous values of waist circumference.</p><p>The receiver operating characteristic (ROC) curves for the clinical equation and for the simplified clinical score are shown for men and women (<xref rid="f1" ref-type="fig">Fig. 1<italic>A</italic></xref>); the DESIR scores with three variables had AROC values slightly higher than for the five-variable FINDRISC score. The score predicted diabetes in the two French cohorts, with the AROCs similar to those from DESIR (online appendix Fig. 1).</p></sec><sec><title>Biologic predictors of incident diabetes</title><p>Fasting glucose was by far the factor most predictive of incident diabetes, with no difference in its effect between men and women (<italic>P</italic> for interaction &#x0003d; 0.1) (<xref ref-type="table" rid="t1">Table 1</xref>). Predictive factors differing between sexes were triglycerides and HDL cholesterol&#x02014;both had a slightly stronger relation in women (<italic>P</italic> for sex interaction &#x0003d; 0.006 and 0.008, respectively).</p></sec><sec><title>Clinical &#x0002b; biological predictors of incident diabetes</title><p>Fasting glucose (including its squared term) was the most predictive of all factors. After adjustment for fasting glucose, waist circumference was more predictive than BMI in men, but BMI was more predictive than waist in women (<xref ref-type="table" rid="t2">Table 2</xref>). In men, the predicting equation included fasting glucose, smoking status, waist circumference, and GGT and in women included fasting glucose, BMI, diabetes in the family, and triglycerides. The same variables were chosen by Cox modeling with five predictive variables. Our (clinical &#x0002b; biological) equation was simpler than the Stern equation with only four variables and discriminated incident diabetic individuals similarly (<xref rid="f1" ref-type="fig">Fig. 1<italic>B</italic></xref>).</p></sec><sec><title>Genetic polymorphisms as predictors of incident diabetes</title><p>None of the four polymorphisms was significantly related to incident diabetes in either men or women, using either the three genotypes or recessive, dominant, or additive models of inheritance (online appendix Table). There was no interaction with sex, and combining men and women, TCF7L2 and IL6 were significantly related with incident diabetes using additive models (<italic>P</italic> &#x0003c; 0.01 and 0.03, respectively). In comparison with individuals with no deleterious alleles, those with four deleterious alleles had an OR of incident diabetes of 3.60 (95&#x00025; CI 1.09&#x02013;11.9) in men and 3.22 (0.62&#x02013;16.5) in women. The number of deleterious alleles was associated with incident diabetes in both men and women (<italic>P</italic> &#x0003c; 0.008 and 0.03, respectively) (<xref ref-type="table" rid="t1">Table 1</xref>). Including the total number of deleterious alleles in the above-determined (clinical &#x0002b; biological) equations, models showed an adequate fit but little changed the AROC (<xref ref-type="table" rid="t2">Table 2</xref>).</p></sec></sec><sec><title>CONCLUSIONS</title><p>Both the clinical and the (clinical &#x0002b; biological) equations are able to predict diabetes incidence over a 9-year follow-up, with different variables in the equations for men and women. Age was not selected in any of the equations, but age is highly correlated with adiposity, hypertension, and glucose levels, all of which appear in the equations. Age was included in the equations of many (<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r8">8</xref>&#x02013;<xref ref-type="bibr" rid="r10">10</xref>) but not all (<xref ref-type="bibr" rid="r7">7</xref>) of the other published studies of risk equations. Polymorphisms added little to these scores. As expected, the equations derived on our population performed slightly better than those derived in other populations. The clinical score performed well on two other French cohorts.</p><p>Our diabetes risk score based on clinical data has the advantage that it is simple and requires only three parameters. Given a larger population and a higher incidence of diabetes, other parameters might have been included in the equations, but the discrimination and model fit may not be greatly improved. BMI and waist circumference had similarly predictive values in both men and women; once one was included, the other no longer entered the model. Similar comments can be made for GGT and ALT.</p><p>In contrast to other scores, we have studied men and women separately and found that the predictive equations differ. In both sexes, waist circumference was the clinical factor most related to incident diabetes; the next most predictive factor in men was smoking, which was more common in men than women; and in women only, diabetes in the family was a predictive factor. Hypertension was predictive of diabetes in both sexes, a factor often present before diabetes (<xref ref-type="bibr" rid="r17">17</xref>). Smoking is recognized as a risk factor for diabetes, with a higher risk for the heavy smokers in comparison with the lighter and former smokers (<xref ref-type="bibr" rid="r18">18</xref>). Our observation that more diabetic women than men have diabetes in the family is probably due to women being more aware of their family history of diabetes. In the multivariate equations, physical activity was not predictive&#x02014;this could be because of its negative correlation with waist circumference and hypertension and perhaps because our questions on self-reported physical activity were not sufficiently precise, in comparison with other data such as waist circumference and hypertension. Other studies have indeed included physical activity in their multivariate equations (<xref ref-type="bibr" rid="r3">3</xref>,<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r8">8</xref>).</p><p>The overriding biological factor predictive of diabetes was the baseline glucose level. In the (clinical &#x0002b; biological) equation in men, the GGT also entered the equation and in women the triglycerides concentration entered. We have already shown that GGT is predictive of incident diabetes in this cohort for both sexes (<xref ref-type="bibr" rid="r19">19</xref>), and others have shown that triglycerides are predictive (<xref ref-type="bibr" rid="r5">5</xref>,<xref ref-type="bibr" rid="r10">10</xref>).</p><p>The polymorphisms studied provided little toward predicting diabetes: for the 1,655 men and 1,740 women with these data available, the Hosmer-Lemeshow tests showed a poorer fit for men when the genetic data were included but identical AROCs. Of note, in women, the coefficient for the parameter of diabetes in the family was only reduced from 0.80 to 0.75 when genetic parameters were included, indicating that other possible genetic factors are involved. A large panel of SNPs may be needed to outperform even simple clinical parameters.</p><p>One of the limitations is that we have not been able to include the 2-h glucose concentration in our definition of diabetes&#x02014;in France, screening of diabetes with fasting glucose is common; our score is therefore appropriate in the local situation. A further limitation is that the score is only for people between 30 and 65 years of age.</p><p>The simplest clinical parameter for identifying those at risk of diabetes is adiposity, and taken alone, either waist circumference or BMI did equally well in predicting later diabetes during the 9-year follow-up. The addition of hypertension, smoking in men, and triglycerides in women provides a clinical score that discriminates well.</p><sec><title>The DESIR study group</title><p>INSERM U780: B. Balkau, P. Ducimeti&#x000e8;re, and E. Eschw&#x000e8;ge; INSERM U367: F. Alhenc-Gelas; CHU D'Angers: Y. Gallois, and A. Girault; Bichat Hospital: F. Fumeron, and M. Marre; CNRS UMR8090, Lille: P. Froguel; Centres d'Examens de Sant&#x000e9;: Alen&#x000e7;on, Angers, Caen, Chateauroux, Cholet, Le Mans, Tours; Institute de Recherche M&#x000e9;decine G&#x000e9;n&#x000e9;rale: J. Cogneau; general practitioners of the region; Institute inter-Regional pour la Sant&#x000e9;: C. Born, E. Caces, M. Cailleau, J.G. Moreau, F. Rakotozafy, J. Tichet, and S. Vol.</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material id="PMC_1" content-type="local-data"><caption><title>Online-Only Appendix</title></caption><media mimetype="text" mime-subtype="html" xlink:href="dc08-0368_index.html"/><media xlink:role="associated-file" mimetype="application" mime-subtype="msword" xlink:href="dc08-0368_ONLINE_TABLE_FOR_ONLINE_APPENDIX.doc"/></supplementary-material></sec></body><back><ack><p>DESIR has been supported by INSERM contracts with CNAMTS (Caisse Nationale d'Assurance Maladie des Travailleurs Salari&#x000e9;s &#x0005b;French National Health Insurance Agency for Wage Earners&#x0005d;), Lilly, Novartis Pharma, and sanofi-aventis; by INSERM (R&#x000e9;seaux en Sant&#x000e9; Publique, Interactions entre les d&#x000e9;terminants de la sant&#x000e9;), the Association Diab&#x000e8;te Risque Vasculaire, the F&#x000e9;d&#x000e9;ration Fran&#x000e7;aise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sant&#x000e9;, Novo Nordisk, Pierre Fabre, Roche, and Topcon.</p><p>We thank Francoise Clavel-Chapelon and Serge Hercberg for making their data available from the E3N and SU.VI.MAX studies, respectively, for the validation of our clinical risk score, and Sylviane Vol and Ga&#x000eb;lle Gusto for their careful reading and criticisms of the manuscript.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal">Waugh N, Scotland G, McNamee P, Gillett M, Brennan A, Goyder E, Williams R, John A: Screening for type 2 diabetes: literature review and economic modelling. <source>Health Technol Assess</source><volume>11</volume>:<fpage>1</fpage>&#x02013;125, <year>2007</year></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal">Balkau B, Sapinho D, Petrella A, Mhamdi L, Cailleau M, Arondel D, Charles MA; D.E.S.I.R. Study Group: Prescreening tools for diabetes and obesity-BMI, waist and waist hip ratio: the D.E.S.I.R. <source>Study Eur J Clin Nutr</source><volume>60</volume>:<fpage>295</fpage>&#x02013;304, <year>2006</year></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal">Lindstr&#x000f6;m J, Tuomilehto J: The diabetes risk score: a practical tool to predict type 2 diabetes risk. <source>Diabetes Care</source><volume>26</volume>:<fpage>725</fpage>&#x02013;731, <year>2003</year><pub-id pub-id-type="pmid">12610029</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal">Saaristo T, Peltonen M, Lindstr&#x000f6;m J, Saarikoski L, Sundvall J, Eriksson JG, Tuomilehto J: Cross-sectional evaluation of the Finnish Diabetes Risk Score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome. <source>Diab Vasc Dis Res</source><volume>2</volume>:<fpage>67</fpage>&#x02013;72, <year>2005</year><pub-id pub-id-type="pmid">16305061</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal">Schmidt MI, Duncan BB, Bang H, Pankow JS, Ballantyne CM, Golden SH, Folsom AR, Chambless LE; The Atherosclerosis Risk in Communities Investigators: Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. <source>Diabetes Care</source><volume>28</volume>:<fpage>2013</fpage>&#x02013;2018, <year>2005</year><pub-id pub-id-type="pmid">16043747</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal">Aekplakorn W, Bunnag P, Woodward M, Sritara P, Cheepudomwit S, Yamwong S, Yipintsoi T, Rajatanavin R: A risk score for predicting incident diabetes in the Thai population. <source>Diabetes Care</source><volume>29</volume>:<fpage>1872</fpage>&#x02013;1877, <year>2006</year><pub-id pub-id-type="pmid">16873795</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal">Simmons RK, Harding AH, Wareham NJ, Griffin SJ; EPIC-Norfolk Project Team: Do simple questions about diet and physical activity help to identify those at risk of type 2 diabetes? <source>Diabet Med</source><volume>24</volume>:<fpage>830</fpage>&#x02013;835, <year>2007</year><pub-id pub-id-type="pmid">17490419</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal">Schulze MB, Hoffmann K, Boeing H, Linseisen J, Rohrmann S, Mohlig M, Pfeiffer AF, Spranger J, Thamer C, H&#x000e4;ring HU, Fritsche A, Joost HG: An accurate risk score based on anthropometric, dietary, and lifestyle factors to predict the development of type 2 diabetes. <source>Diabetes Care</source><volume>30</volume>:<fpage>510</fpage>&#x02013;515, <year>2007</year><pub-id pub-id-type="pmid">17327313</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal">Stern MP, Williams K, Haffner SM: Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test? <source>Ann Intern Med</source><volume>136</volume>:<fpage>575</fpage>&#x02013;581, <year>2002</year><pub-id pub-id-type="pmid">11955025</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal">Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D'Agostino RB Sr: Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. <source>Arch Intern Med</source><volume>167</volume>:<fpage>1068</fpage>&#x02013;1074, <year>2007</year><pub-id pub-id-type="pmid">17533210</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal">Lecomte P, Vol S, Caces E, Born C, Chabrolle C, Lasfargues G, Halimi JM, Tichet J: Five-year predictive factors of type 2 diabetes in men with impaired fasting glucose. <source>Diabete Metab</source><volume>33</volume>:<fpage>140</fpage>&#x02013;147, <year>2007</year><pub-id pub-id-type="pmid">17320447</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal">Rathmann W, Martin S, Haastert B, Icks A, Holle R, L&#x000f6;wel H, Giani G; KORA Study Group: Performance of screening questionnaires and risk scores for undiagnosed diabetes: the KORA Survey 2000. <source>Arch Intern Med</source><volume>165</volume>:<fpage>436</fpage>&#x02013;441, <year>2005</year><pub-id pub-id-type="pmid">15738374</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal">Gl&#x000fc;mer C, Vistisen D, Borch-Johnsen K, Colagiuri S; DETECT-2 Collaboration: Risk scores for type 2 diabetes can be applied in some populations but not all. <source>Diabetes Care</source><volume>29</volume>:<fpage>410</fpage>&#x02013;414, <year>2006</year><pub-id pub-id-type="pmid">16443896</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal">Clavel-Chapelon F, van Liere MJ, Giubout C, Niravong MY, Goulard H, Le Corre C, Hoang LA, Amoyel J, Auquier A, Duauesnel E: E3N, a French cohort study on cancer risk factors: E3N Group: Etude Epidemiologique aupres de femmes de l'Education Nationale. <source>Eur J Cancer Prev</source><volume>6</volume>:<fpage>473</fpage>&#x02013;478, <year>1997</year><pub-id pub-id-type="pmid">9466118</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal">Czernichow S, Couthouis A, Bertrais S, Vergnaud AC, Dauchet L, Galan P, Hercberg S: Antioxidant supplementation does not affect fasting plasma glucose in the Supplementation with Antioxidant Vitamins and Minerals (SU.VI.MAX) study in France: association with dietary intake and plasma concentrations. <source>Am J Clin Nutr</source><italic>2006</italic><volume>84</volume>:<fpage>395</fpage>&#x02013;399, <year>2006</year><pub-id pub-id-type="pmid">16895889</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal">Vaxillaire M, Veslot J, Dina C, Proen&#x000e7;a C, Cauchi S, Charpentier G, Tichet J, Fumeron F, Marre M, Meyre D, Balkau B, Froguel P; for the DESIR Study Group: Impact of common type 2 diabetes risk polymorphisms in the DESIR prospective study. <source>Diabetes</source><volume>57</volume>:<fpage>244</fpage>&#x02013;254, <year>2008</year><pub-id pub-id-type="pmid">17977958</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal">Conen D, Ridker PM, Mora S, Buring JE, Glynn RJ: Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. <source>Eur Heart J</source><volume>28</volume>:<fpage>2937</fpage>&#x02013;2943, <year>2007</year><pub-id pub-id-type="pmid">17925342</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal">Willi C, Bodenmann P, Ghali WA, Faris PD, Cornuz J: Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. <source>JAMA</source><volume>298</volume>:<fpage>2654</fpage>&#x02013;2664, <year>2007</year><pub-id pub-id-type="pmid">18073361</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal">Andr&#x000e9; P, Balkau B, Born C, Royer B, Wilpart E, Charles MA, Eschw&#x000e8;ge E: Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study: the D.E.S.I.R. study (Data from an Epidemiological Study on the Insulin Resistance syndrome). <source>Diabet Metab</source><volume>31</volume>:<fpage>542</fpage>&#x02013;550, <year>2005</year></citation></ref></ref-list></back><floats-wrap><fig position="float" id="f1"><label>Figure 1</label><caption><p>ROC curves and AROC statistics in men and women for the DESIR French clinical equation, the French clinical risk score, and the FINDRISC clinical score (<xref ref-type="bibr" rid="r3">3</xref>) (<italic>A</italic>) and for DESIR (clinical &#x0002b; biological) (<italic>B</italic>). French risk equation and Stern risk equation (<xref ref-type="bibr" rid="r9">9</xref>).</p></caption><graphic xlink:href="zdc0100872120001"></graphic></fig><table-wrap position="float" id="t1"><label>Table 1</label><caption><p>Clinical and biological characteristics at baseline of men and women with and without incident diabetes during the 9 years of the DESIR study</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="3" rowspan="1" align="center" valign="bottom">Men <hr/></th><th colspan="3" rowspan="1" align="center" valign="bottom">Women <hr/></th><th colspan="1" rowspan="2" align="center" valign="bottom"><italic>P</italic> for variable</th><th colspan="1" rowspan="2" align="center" valign="bottom"><italic>P</italic> for interaction with sex</th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">Diabetes</th><th colspan="1" rowspan="1" align="center" valign="bottom">No diabetes</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">Diabetes</th><th colspan="1" rowspan="1" align="center" valign="bottom">No diabetes</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P<xref ref-type="table-fn" rid="t1fn1">&#x0002a;</xref></italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top"><italic>n</italic></td><td colspan="1" rowspan="1" align="center" valign="top">140</td><td colspan="1" rowspan="1" align="center" valign="top">1,723</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">63</td><td colspan="1" rowspan="1" align="center" valign="top">1,891</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Age (years)</td><td colspan="1" rowspan="1" align="center" valign="top">50 &#x000b1; 9</td><td colspan="1" rowspan="1" align="center" valign="top">47 &#x000b1; 10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">52 &#x000b1; 8</td><td colspan="1" rowspan="1" align="center" valign="top">47 &#x000b1; 10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0005</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.6</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Diabetes in the family</td><td colspan="1" rowspan="1" align="center" valign="top">28 (20)</td><td colspan="1" rowspan="1" align="center" valign="top">312 (18)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.6</td><td colspan="1" rowspan="1" align="center" valign="top">27 (43)</td><td colspan="1" rowspan="1" align="center" valign="top">368 (19)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="table-fn" rid="t1fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.003</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Current smoker</td><td colspan="1" rowspan="1" align="center" valign="top">52 (37)</td><td colspan="1" rowspan="1" align="center" valign="top">418 (24)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0009</td><td colspan="1" rowspan="1" align="center" valign="top">10 (16)</td><td colspan="1" rowspan="1" align="center" valign="top">249 (13)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.5</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.3</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Alcohol intake (g/day)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">34 &#x000b1; 32</td><td colspan="1" rowspan="1" align="center" valign="top">23 &#x000b1; 22</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.005</td><td colspan="1" rowspan="1" align="center" valign="top">8 &#x000b1; 11</td><td colspan="1" rowspan="1" align="center" valign="top">7 &#x000b1; 11</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.5</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.006<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.2</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Physical activity</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Little</td><td colspan="1" rowspan="1" align="center" valign="top">43 (31)</td><td colspan="1" rowspan="1" align="center" valign="top">422 (24)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">22 (35)</td><td colspan="1" rowspan="1" align="center" valign="top">465 (25)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Moderate</td><td colspan="1" rowspan="1" align="center" valign="top">72 (51)</td><td colspan="1" rowspan="1" align="center" valign="top">911 (53)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.07</td><td colspan="1" rowspan="1" align="center" valign="top">33 (52)</td><td colspan="1" rowspan="1" align="center" valign="top">1036 (55)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.7</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Intensive</td><td colspan="1" rowspan="1" align="center" valign="top">25 (18)</td><td colspan="1" rowspan="1" align="center" valign="top">388 (23)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">8 (13)</td><td colspan="1" rowspan="1" align="center" valign="top">386 (20)</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Waist circumference (cm)</td><td colspan="1" rowspan="1" align="center" valign="top">96 &#x000b1; 10</td><td colspan="1" rowspan="1" align="center" valign="top">89 &#x000b1; 9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">90 &#x000b1; 12</td><td colspan="1" rowspan="1" align="center" valign="top">76 &#x000b1; 10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.3</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">BMI (kg/m<sup>2</sup>)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">27.5 &#x000b1; 4.0</td><td colspan="1" rowspan="1" align="center" valign="top">25.1 &#x000b1; 3.0</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">29.2 &#x000b1; 5.1</td><td colspan="1" rowspan="1" align="center" valign="top">23.7 &#x000b1; 3.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.3</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Menopause</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">30 (48)</td><td colspan="1" rowspan="1" align="center" valign="top">718 (38)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.1</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Large baby, birth weight &#x02265;4 kg</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">16 (27)</td><td colspan="1" rowspan="1" align="center" valign="top">284 (15)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Hypertension<xref ref-type="table-fn" rid="t1fn5">&#x02016;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">87 (62)</td><td colspan="1" rowspan="1" align="center" valign="top">678 (39)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">39 (62)</td><td colspan="1" rowspan="1" align="center" valign="top">527 (28)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Heart rate (min)</td><td colspan="1" rowspan="1" align="center" valign="top">68 &#x000b1; 10</td><td colspan="1" rowspan="1" align="center" valign="top">66 &#x000b1; 10</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.007</td><td colspan="1" rowspan="1" align="center" valign="top">71 &#x000b1; 11</td><td colspan="1" rowspan="1" align="center" valign="top">68 &#x000b1; 9</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0005<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.7</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Treatment for lipids</td><td colspan="1" rowspan="1" align="center" valign="top">20 (14)</td><td colspan="1" rowspan="1" align="center" valign="top">126 (7)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.004</td><td colspan="1" rowspan="1" align="center" valign="top">9 (14)</td><td colspan="1" rowspan="1" align="center" valign="top">129 (7)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0003<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.9</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Fasting glucose (mmol/l)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">6.05 &#x000b1; 0.55</td><td colspan="1" rowspan="1" align="center" valign="top">5.39 &#x000b1; 0.49</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">5.96 &#x000b1; 0.58</td><td colspan="1" rowspan="1" align="center" valign="top">5.11 &#x000b1; 0.46</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">GGT (IU/l)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">64.3 &#x000b1; 67.2</td><td colspan="1" rowspan="1" align="center" valign="top">39.5 &#x000b1; 38.3</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">36.4 &#x000b1; 33.6</td><td colspan="1" rowspan="1" align="center" valign="top">21.7 &#x000b1; 21.2</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.4</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">ALT (UI/l)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">41.7 &#x000b1; 28.3</td><td colspan="1" rowspan="1" align="center" valign="top">30.3 &#x000b1; 18.1</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">28.9 &#x000b1; 22.2</td><td colspan="1" rowspan="1" align="center" valign="top">20.1 &#x000b1; 13.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.4</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Triglycerides (mmol/l)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1.79 &#x000b1; 1.45</td><td colspan="1" rowspan="1" align="center" valign="top">1.26 &#x000b1; 0.80</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top">1.50 &#x000b1; 0.78</td><td colspan="1" rowspan="1" align="center" valign="top">0.93 &#x000b1; 0.50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="table-fn" rid="t1fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.006</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">HDL cholesterol (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">1.41 &#x000b1; 0.37</td><td colspan="1" rowspan="1" align="center" valign="top">1.50 &#x000b1; 0.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="center" valign="top">1.53 &#x000b1; 0.34</td><td colspan="1" rowspan="1" align="center" valign="top">1.80 &#x000b1; 0.42</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top"><xref ref-type="table-fn" rid="t1fn3">&#x02021;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.008</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Total cholesterol (mmol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">6.06 &#x000b1; 1.05</td><td colspan="1" rowspan="1" align="center" valign="top">5.82 &#x000b1; 0.97</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.009</td><td colspan="1" rowspan="1" align="center" valign="top">5.94 &#x000b1; 1.04</td><td colspan="1" rowspan="1" align="center" valign="top">5.61 &#x000b1; 0.96</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.6</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Creatinine (&#x003bc;mol/l)</td><td colspan="1" rowspan="1" align="center" valign="top">91.0 &#x000b1; 13.9</td><td colspan="1" rowspan="1" align="center" valign="top">89.1 &#x000b1; 11.1</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="center" valign="top">77.1 &#x000b1; 10.7</td><td colspan="1" rowspan="1" align="center" valign="top">74.1 &#x000b1; 10.0</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.006<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.4</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">White blood cell count (10<sup>9</sup>/l)<xref ref-type="table-fn" rid="t1fn4">&#x000a7;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">6.9 &#x000b1; 2.1</td><td colspan="1" rowspan="1" align="center" valign="top">6.4 &#x000b1; 1.7</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td><td colspan="1" rowspan="1" align="center" valign="top">7.3 &#x000b1; 4.0</td><td colspan="1" rowspan="1" align="center" valign="top">6.2 &#x000b1; 1.6</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001<xref ref-type="table-fn" rid="t1fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.2</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;<italic>n</italic></td><td colspan="1" rowspan="1" align="char" char="." valign="top">135</td><td colspan="1" rowspan="1" align="center" valign="top">1,617</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top">61</td><td colspan="1" rowspan="1" align="center" valign="top">1,782</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Number of TCF7L2 and IL6 deleterious alleles</td><td colspan="1" rowspan="1" align="center" valign="top">2.0</td><td colspan="1" rowspan="1" align="center" valign="top">1.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.008</td><td colspan="1" rowspan="1" align="center" valign="top">2.2</td><td colspan="1" rowspan="1" align="center" valign="top">1.8</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0007</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.7</td></tr></tbody></table><table-wrap-foot><fn><p>Data are means &#x000b1; SD and <italic>n</italic> (&#x00025;) unless otherwise indicated.</p></fn><fn id="t1fn1"><label>&#x0002a;</label><p><italic>P</italic> comparing means and percentages by <italic>t</italic> and &#x003c7;<sup>2</sup> tests.</p></fn><fn id="t1fn2"><label>&#x02020;</label><p><italic>P</italic> for variable in logistic model with only variable and sex, as interaction not significant.</p></fn><fn id="t1fn3"><label>&#x02021;</label><p><italic>P</italic> for variable not given, as the interaction is significant.</p></fn><fn id="t1fn4"><label>&#x000a7;</label><p>Log transformation because of a nonsymmetric distribution.</p></fn><fn id="t1fn5"><label>&#x02016;</label><p>Hypertension: systolic/diastolic blood pressure &#x02265;140/90 mmHg or medication for hypertension.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t2"><label>Table 2</label><caption><p>&#x003b2;-Coefficients for the clinical, clinical &#x0002b; biological, and clinical &#x0002b; biological &#x0002b; genetic equations: the DESIR study</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="2" rowspan="1" align="center" valign="bottom">Clinical equation <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">Clinical &#x0002b; biological equation <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom">Clinical &#x0002b; biological &#x0002b; genetic equation <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="2" rowspan="1" align="center" valign="bottom"><italic>n</italic> &#x0003d; 1,860 men (140 with diabetes) and <italic>n</italic> &#x0003d; 1,954 women (63 with diabetes) <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom"><italic>n</italic> &#x0003d; 1,860 men (140 with diabetes) and <italic>n</italic> &#x0003d; 1,954 women (63 with diabetes) <hr/></th><th colspan="2" rowspan="1" align="center" valign="bottom"><italic>n</italic> &#x0003d; 1,655 men (128 with diabetes) and <italic>n</italic> &#x0003d; 1,740 women (58 with diabetes) <hr/></th></tr><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">&#x003b2;</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">&#x003b2;</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th><th colspan="1" rowspan="1" align="center" valign="bottom">&#x003b2;</th><th colspan="1" rowspan="1" align="center" valign="bottom"><italic>P</italic></th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Men</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Intercept</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;10.45</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;10.53</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">10.91</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Current smoker</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.72</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.88</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.94</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference (cm)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.081</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.060</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.060</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hypertension<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.50</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose (mmol/l)<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">10.15</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">10.17</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose<sup>2</sup><xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">24.16</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.002</td><td colspan="1" rowspan="1" align="char" char="." valign="top">22.42</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.007</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;GGT (IU/l)<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.39</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.42</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.007</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Number of TCF7L2 and IL6 deleterious alleles</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.14</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.2</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AROC statistic</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.733</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.850</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.851</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hosmer-Lemeshow fit test</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.7</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.8</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Women</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Intercept</td><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;11.81</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;18.91</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">&#x02212;20.43</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Diabetes in the family</td><td colspan="1" rowspan="1" align="char" char="." valign="top">1.09</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.80</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.75</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.02</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference (cm)</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.095</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;BMI (kg/m<sup>2</sup>)<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">4.38</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">4.69</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.0001</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hypertension<xref ref-type="table-fn" rid="t2fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.64</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.03</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose (mmol/l)<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">9.66</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.001</td><td colspan="1" rowspan="1" align="char" char="." valign="top">9.35</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.001</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Fasting glucose<sup>2</sup><xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">23.89</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.06</td><td colspan="1" rowspan="1" align="char" char="." valign="top">22.39</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.08</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Triglycerides (mmol/l)<xref ref-type="table-fn" rid="t2fn2">&#x02020;</xref></td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.95</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.003</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.86</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.01</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Number of TCF7L2 amd IL6 deleterious alleles</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.36</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.04</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AROC statistic</td><td colspan="1" rowspan="1" align="char" char="." valign="top">0.839</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.917</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.912</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hosmer-Lemeshow fit test</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.6</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.9</td><td colspan="1" rowspan="1" align="center" valign="top"/><td colspan="1" rowspan="1" align="char" char="." valign="top">0.8</td></tr></tbody></table><table-wrap-foot><fn id="t2fn1"><label>&#x0002a;</label><p>Systolic/diastolic blood pressure &#x02265;140/90 mmHg or medication for hypertension.</p></fn><fn id="t2fn2"><label>&#x02020;</label><p>Fasting glucose, GGT, BMI, and triglycerides were log transformed.</p></fn></table-wrap-foot></table-wrap><table-wrap position="float" id="t3"><label>Table 3</label><caption><p>A clinical diabetes risk score of 5 confers a &#x0003e;30&#x00025; chance of diabetes in the following 9 years: the DESIR study</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="1" rowspan="1" align="center" valign="bottom"/><th colspan="1" rowspan="1" align="center" valign="bottom">Scores to sum</th></tr></thead><tbody><tr><td colspan="1" rowspan="1" align="left" valign="top">Men</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference (cm)</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x0003c;80</td><td colspan="1" rowspan="1" align="center" valign="top">0</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;80&#x02013;89</td><td colspan="1" rowspan="1" align="center" valign="top">1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;90&#x02013;99</td><td colspan="1" rowspan="1" align="center" valign="top">2</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02265;100</td><td colspan="1" rowspan="1" align="center" valign="top">3</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Current smoker: yes</td><td colspan="1" rowspan="1" align="center" valign="top">1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hypertension: yes<xref ref-type="table-fn" rid="t3fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AROC statistic</td><td colspan="1" rowspan="1" align="center" valign="top">0.713</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hosmer-Lemeshow fit test</td><td colspan="1" rowspan="1" align="center" valign="top"><italic>P</italic> &#x0003d; 0.8</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">Women</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Waist circumference (cm)</td><td colspan="1" rowspan="1" align="center" valign="top"/></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x0003c;70</td><td colspan="1" rowspan="1" align="center" valign="top">0</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;70&#x02013;79</td><td colspan="1" rowspan="1" align="center" valign="top">1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;80&#x02013;89</td><td colspan="1" rowspan="1" align="center" valign="top">2</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02003;&#x02265;90</td><td colspan="1" rowspan="1" align="center" valign="top">3</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Diabetes in the family: yes</td><td colspan="1" rowspan="1" align="center" valign="top">1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hypertension: yes<xref ref-type="table-fn" rid="t3fn1">&#x0002a;</xref></td><td colspan="1" rowspan="1" align="center" valign="top">1</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;AROC statistic</td><td colspan="1" rowspan="1" align="center" valign="top">0.827</td></tr><tr><td colspan="1" rowspan="1" align="left" valign="top">&#x02003;&#x02003;&#x02003;&#x02003;Hosmer-Lemeshow fit test</td><td colspan="1" rowspan="1" align="center" valign="top"><italic>P</italic> &#x0003d; 0.9</td></tr></tbody></table><table-wrap-foot><fn id="t3fn1"><label>&#x0002a;</label><p>Systolic/diastolic blood pressure &#x02265;140/90 mmHg or medication for hypertension.</p></fn></table-wrap-foot></table-wrap></floats-wrap></article> 